MAMMOSCREEN takes part in the first Annual Meeting of the Cancer Mission Cluster “Prevention and early detection (Screening)” The first annual meeting of the “Prevention and early detection (screening)” Cluster…
MammoScreen launches the Hereditary Breast Cancer Questionnaire In August 2023, the Hereditary Breast Cancer Questionnaire was launched as part of the MammoScreen project that ELAROS is a part of. ELAROS worked…
ELAROS joins MammoScreen in organising webinar “Shaping the future of Breast Cancer screening: introducing the MammoScreen project” The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups was held on…
Opinion piece published in the British Medical Journal Published on the 10th of August 2023 in the British Medical Journal doi: 10.1136/bmj.p1816 'Digital interactive patient reported outcome measures for long…
MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects…
ROVER: ELAROS delivers an industrial visit to University of Florence ELAROS Director of Research and Development, Román Rocha Lawrence, delivered a two week industrial visit to the Università degli Studi…
MammoScreen holds its first in person consortium meeting On the 17th and 18th of May, ELAROS had the exciting opportunity to attend the first MammoScreen Consortium Meeting at London Southbank…
The Press and Journal Evening Express announce adoption of digital C19- YRS in NHS Highland'I feel like I'm one of the lucky ones': New long Covid service in Highlands gives…
ELAROS and University of Leeds secure ESRC funding for a new research fellowship focused on our existing joint work around long Covid ELAROS is delighted to announced that we, alongside…
ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS is delighted to be able to announce that we…